会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHODS AND COMPOSITIONS FOR THE TARGETED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS
    • 用于有针对性地提供生物活性剂的方法和组合物
    • US20060141041A1
    • 2006-06-29
    • US10342448
    • 2003-01-14
    • Mark TracyDavid Scher
    • Mark TracyDavid Scher
    • A61K38/21A61K38/20A61K38/19A61K9/14
    • A61K9/1647Y02A50/411Y02A50/423
    • The present invention relates to a sustained release composition for the targeted delivery of biologically active agents to specific tissues and cells. The composition comprises microparticles containing a biocompatible polymer, a water-soluble polymer and a biologically active agent. In one embodiment, the biologically active agent is an antigen or an immunomodulator. In another embodiment, the biologically is a labile agent. The microparticles have a number median diameter of greater than 20 microns upon administration. The water-soluble polymer is present in the sustained released composition in at least about 20% of the dry weight of the microparticle. the sustained release composition provides for the dissolution of the water-soluble polymer of the composition upon hydration, at a much greater rate than the degradation of the biocompatible polymer. This variance is solubility generates pseudo-microparticles which have a number median diameter which is substantially smaller than the size of the administered microparticles. The pseudo-microparticles can be engulfed by antigen presenting cells of the immune system, or absorbed by the Peyer's patches in the gut.
    • 本发明涉及用于将生物活性剂靶向递送至特定组织和细胞的持续释放组合物。 该组合物包含含有生物相容性聚合物,水溶性聚合物和生物活性剂的微粒。 在一个实施方案中,生物活性剂是抗原或免疫调节剂。 在另一个实施方案中,生物学上是不稳定剂。 微粒在给药时的中值直径大于20微米。 水溶性聚合物以至少约20%的微粒干重存在于持续释放的组合物中。 持续释放组合物提供组合物的水溶性聚合物在水合时以比生物相容性聚合物降解更大的速率溶解。 这种方差是溶解度产生具有基本上小于施用的微粒尺寸的数字中值直径的假微粒。 伪微粒可以被免疫系统的抗原呈递细胞吞噬,或被肠道中的派耶氏斑块吸收。